Brokerages Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $79.30

Henry Schein, Inc. (NASDAQ:HSIC) has received an average recommendation of “Moderate Buy” from the eleven analysts that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $79.30.

HSIC has been the subject of several recent research reports. Barrington Research reduced their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a report on Tuesday, May 6th. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Piper Sandler reduced their target price on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a report on Wednesday, April 30th. Wells Fargo & Company dropped their price target on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Finally, Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th.

Insider Activity

In other news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company’s stock, valued at $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.08% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds have recently bought and sold shares of the business. Smartleaf Asset Management LLC increased its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the period. Guggenheim Capital LLC increased its position in Henry Schein by 2.5% during the fourth quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock worth $445,000 after acquiring an additional 159 shares during the period. CIBC Asset Management Inc increased its position in Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock worth $1,235,000 after acquiring an additional 169 shares during the period. Metis Global Partners LLC increased its position in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after acquiring an additional 187 shares during the period. Finally, UMB Bank n.a. increased its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after acquiring an additional 201 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Down 1.3%

Henry Schein stock opened at $70.19 on Tuesday. The stock has a market capitalization of $8.54 billion, a PE ratio of 28.88, a price-to-earnings-growth ratio of 2.13 and a beta of 0.86. Henry Schein has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a 50 day moving average of $68.30 and a 200-day moving average of $71.43.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same quarter in the prior year, the company posted $1.10 earnings per share. The firm’s revenue was down .1% on a year-over-year basis. On average, equities research analysts anticipate that Henry Schein will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.